144 related articles for article (PubMed ID: 33200391)
21. Advanced Eales' Disease With Neovascular Glaucoma at First Presentation.
Alfayyadh MA; Alabdulhadi HA; Almubarak MH
Cureus; 2021 Sep; 13(9):e18302. PubMed ID: 34722077
[TBL] [Abstract][Full Text] [Related]
22. The evaluation of patients with Eales' disease.
Renie WA; Murphy RP; Anderson KC; Lippman SM; McKusick VA; Proctor LR; Shimizu H; Patz A; Fine SL
Retina; 1983; 3(4):243-8. PubMed ID: 6675099
[TBL] [Abstract][Full Text] [Related]
23. [Eales' disease].
Errera MH; Pratas A; Goldschmidt P; Sedira N; Sahel JA; Benesty J
J Fr Ophtalmol; 2016 May; 39(5):474-82. PubMed ID: 27185661
[TBL] [Abstract][Full Text] [Related]
24. Eales' disease: the great masquerader.
Davis J; Schecter SH; Sowka J
Optometry; 2009 Jul; 80(7):354-9. PubMed ID: 19545848
[TBL] [Abstract][Full Text] [Related]
25. Determination of carbonyl group content in plasma proteins as a useful marker to assess impairment in antioxidant defense in patients with Eales' disease.
Rajesh M; Sulochana KN; Coral K; Punitham R; Biswas J; Babu K; Ramakrishnan S
Indian J Ophthalmol; 2004 Jun; 52(2):139-44. PubMed ID: 15283219
[TBL] [Abstract][Full Text] [Related]
26. Choroidal Tuberculoma Manifesting in A Patient of Eales Disease 6 Years after Initial Presentation.
Magesan K; Dutta Majumder P
Ocul Immunol Inflamm; 2020; 28(1):100-102. PubMed ID: 30339475
[No Abstract] [Full Text] [Related]
27. Evaluation of lymphocyte proliferation assay to purified protein derivative, enzyme linked immunosorbant assay, and tuberculin hypersensitivity in Eales' disease.
Biswas J; Narain S; Roy S; Madhavan HN
Indian J Ophthalmol; 1997 Jun; 45(2):93-7. PubMed ID: 9475026
[TBL] [Abstract][Full Text] [Related]
28. Full panretinal photocoagulation and early vitrectomy improve prognosis of retinal vasculitis associated with tuberculoprotein hypersensitivity (Eales' disease).
El-Asrar AM; Al-Kharashi SA
Br J Ophthalmol; 2002 Nov; 86(11):1248-51. PubMed ID: 12386081
[TBL] [Abstract][Full Text] [Related]
29. Surgical outcomes of minimally invasive vitrectomy surgery in Eales' disease.
Khanduja S; Gupta S; Sinha S; Venkatesh P; Vohra R; Garg S
Nepal J Ophthalmol; 2013; 5(2):182-9. PubMed ID: 24172552
[TBL] [Abstract][Full Text] [Related]
30. Surgical outcomes for vitrectomy in Eales' disease.
Shukla D; Kanungo S; Prasad NM; Kim R
Eye (Lond); 2008 Jul; 22(7):900-4. PubMed ID: 17401324
[TBL] [Abstract][Full Text] [Related]
31. Visualization of retinal vasculitis in Eales' disease.
Atmaca LS; Idil A; Gündüz K
Ocul Immunol Inflamm; 1993; 1(1-2):41-8. PubMed ID: 22827191
[TBL] [Abstract][Full Text] [Related]
32. Eales' disease: accumulation of reactive oxygen intermediates and lipid peroxides and decrease of antioxidants causing inflammation, neovascularization and retinal damage.
Bhooma V; Sulochana KN; Biswas J; Ramakrishnan S
Curr Eye Res; 1997 Feb; 16(2):91-5. PubMed ID: 9068938
[TBL] [Abstract][Full Text] [Related]
33. Review of people with retinal vasculitis and positive QuantiFERON
Brunner DR; Zweifel SA; Barthelmes D; Meier F; Böni C
Int Ophthalmol; 2018 Dec; 38(6):2389-2395. PubMed ID: 29027603
[TBL] [Abstract][Full Text] [Related]
34. Unilateral Eales' disease a case report.
Nicolcescu A; Mocanu C; Dinu L; Olaru A; Ionete M; Stefanescu DA
Rom J Ophthalmol; 2017; 61(2):144-149. PubMed ID: 29450389
[No Abstract] [Full Text] [Related]
35. Respiratory disease in the ophthalmology department. Diagnosis: retinal vasculitis associated with tuberculoprotein hypersensitivity (Eales' disease).
Quint JK; Elsheikh A; Yung B; Samuel J; Mukherjee DK
Thorax; 2007 Jun; 62(6):520, 526. PubMed ID: 17536031
[No Abstract] [Full Text] [Related]
36. Intravitreal steroids may facilitate treatment of Eales' disease (idiopathic retinal vasculitis): an interventional case series.
Ishaq M; Feroze AH; Shahid M; Baig MA; Ameen SS; Feroze SH; Chishti RA
Eye (Lond); 2007 Nov; 21(11):1403-5. PubMed ID: 16980931
[TBL] [Abstract][Full Text] [Related]
37. A comparative study of epiretinal membranes associated with Eales' disease: a clinicopathologic evaluation.
Majji AB; Vemuganti GK; Shah VA; Singh S; Das T; Jalali S
Eye (Lond); 2006 Jan; 20(1):46-54. PubMed ID: 15877102
[TBL] [Abstract][Full Text] [Related]
38. Long-Term Outcomes of a Large Cohort of Patients with Eales' Disease.
Biswas J; K R R; Pal B; Gondhale HP; Kharel Sitaula R
Ocul Immunol Inflamm; 2018; 26(6):870-876. PubMed ID: 28448727
[TBL] [Abstract][Full Text] [Related]
39. Raised platelet thiobarbituric acid-reacting substances in proliferative Eales' disease.
Srivastava P; Saxena S; Khanna VK; Kumar D; Nath R; Seth PK
Indian J Ophthalmol; 2000 Dec; 48(4):307-9. PubMed ID: 11340890
[TBL] [Abstract][Full Text] [Related]
40. Eales Disease.
Khan MN; Raza SS; Qadir S; Rehman H; Hussain AK; Nadeem MD; Ullah F
J Ayub Med Coll Abbottabad; 2016; 28(4):816-817. PubMed ID: 28586583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
